Ludwig study extends potential for personalized immunotherapy to large variety of cancers

(Ludwig Institute for Cancer Research) A Ludwig Cancer Research study shows that ovarian cancer, which has proved resistant to currently available immunotherapies, could be susceptible to personalized immunotherapy.